Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2a Study of VB119 in Adult Subjects With Primary Membranous Nephropathy

NCT04652570 is registered in ClinicalTrials.gov with Tenet Medicines as lead sponsor.

NCT NCT04652570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04652570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2a Study of VB119 in Adult Subjects With Primary Membranous Nephropathy
Lead sponsor
Tenet Medicines
Phase
Phase 1/2
Overall status
Terminated
Start date
May 5, 2021
Completion date
August 15, 2024
Enrollment
6 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

membranous nephropathy